Product
Photodynamic therapy
2 clinical trials
2 indications
Indication
Superficial Basal Cell CarcinomaIndication
PericoronitisClinical trial
A Randomized, Double Blind, Vehicle-controlled Multicenter Phase III Study to Evaluate the Safety and Efficacy of BF-200 ALA (Ameluz®) and BF-RhodoLED® in the Treatment of Superficial Basal Cell Carcinoma (sBCC) With Photodynamic Therapy (PDT).Status: Active (not recruiting), Estimated PCD: 2024-03-19
Clinical trial
Evaluation of Photodynamic Therapy in Pericoronitis: a Randomized, Controlled, Double-blind Clinical StudyStatus: , Estimated PCD: 2024-04-20